Sphingolipid metabolism and neutral sphingomyelinases

Handbook of Experimental Pharmacology

Volumn 215, Issue , 2013, Pages 57-76

  Airola, Michael V ^a   Hannun, Yusuf A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Ceramide; Neutral sphingomyelinase; Sphingolipid metabolism; Sphingomyelin; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; ENZYME; MITOCHONDRIAL ASSOCIATED NEUTRAL SPHINGOMYELINASE; NEUTRAL SPHINGOMYELINASE 1; NEUTRAL SPHINGOMYELINASE 2; NEUTRAL SPHINGOMYELINASE 3; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ARTICLE; BONE MINERALIZATION; CELL DEATH; CELL PROLIFERATION; CELL STRESS; CHEMICAL STRUCTURE; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVITY; EXOSOME; HUMAN; HYDROLYSIS; INFLAMMATION; LIPID METABOLISM; LUNG DISEASE; LYSOSOME STORAGE DISEASE; METABOLITE; MOLECULE; NEOPLASM; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPHINGOLIPID METABOLISM; ANIMAL; BONE DEVELOPMENT; CHEMISTRY; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BONE DEVELOPMENT; HUMANS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE;

MLCS; MLOWN;

EID: 84880408384     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-7091-1368-4_3     Document Type: Article

References (78)

1. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J, Kronke M (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86(6):937-947, S0092-8674(00)80169-5 [pii]
2. Ago H, Oda M, Takahashi M, Tsuge H, Ochi S, Katunuma N, Miyano M, Sakurai J (2006) Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus. J Biol Chem 281(23):16157-16167. doi:10.1074/jbc.M601089200, M601089200 [pii]
3. Arana L, Gangoiti P, Ouro A, Trueba M, Gómez-Muñoz A (2010) Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis 9:15
4. Aubin I, Adams CP, Opsahl S, Septier D, Bishop CE, Auge N, Salvayre R, Negre-Salvayre A, Goldberg M, Guenet JL, Poirier C (2005) A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet 37(8):803-805. doi:10.1038/ng1603, ng1603 [pii]
5. Bartke N, Hannun YA (2009) Bioactive sphingolipids: Metabolism and function. J Lipid Res 50(Suppl):S91-S96. doi:10.1194/jlr.R800080-JLR200, R800080-JLR200 [pii]
6. Ben-David O, Futerman AH (2010) The role of the ceramide acyl chain length in neurodegeneration: Involvement of ceramide synthases. Neuromolecular Med 12(4):341-350
7. Bernardo K, Krut O, Wiegmann K, Kreder D, Micheli M, Schafer R, Sickman A, Schmidt WE, Schroder JM, Meyer HE, Sandhoff K, Kronke M (2000) Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain. J Biol Chem 275 (11):7641-7647
8. Canals D, Perry DM, Jenkins RW, Hannun YA (2011) Drug targeting of sphingolipid metabolism: Sphingomyelinases and ceramidases. Br J Pharmacol 163(4):694-712. doi:10.1111/j.1476-5381.2011.01279.x
9. Chen X, Liang H, Zhang J, Zen K, Zhang CY (2012) Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol 22:125-132
10. Clarke CJ, Snook CF, Tani M, Matmati N, Marchesini N, Hannun YA (2006) The extended family of neutral sphingomyelinases. Biochemistry 45(38):11247-11256. doi:10.1021/bi061307z
11. Clarke CJ, Truong TG, Hannun YA (2007) Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: P38 MAPK is an upstream regulator of nSMase2. J Biol Chem 282(2):1384-1396. doi:10.1074/jbc.M609216200, M609216200 [pii]
12. Clarke CJ, Guthrie JM, Hannun YA (2008) Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells. Mol Pharmacol 74(4):1022-1032. doi:10.1124/mol.108.046250, mol.108.046250 [pii]
13. Clarke CJ, Wu BX, Hannun YA (2011a) The neutral sphingomyelinase family: Identifying biochemical connections. Adv Enzyme Regul 51(1):51-58. doi:10.1016/j.advenzreg.2010.09.016, S0065-2571(10)00075-0 [pii]
14. Clarke CJ, Mediwala K, Jenkins RW, Sutton CA, Tholanikunnel BG, Hannun YA (2011b) Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase. J Biol Chem 286(24):21565-21576. doi:10.1074/jbc.M110.193375, M110.193375 [pii]
15. Clarke CJ, Cloessner EA, Roddy PL, Hannun YA (2011c) Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-alpha in MCF-7 cells. Biochem J 435(2):381-390. doi:10.1042/BJ20101752, BJ20101752 [pii]
16. Corcoran CA, He Q, Ponnusamy S, Ogretmen B, Huang Y, Sheikh MS (2008) Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies. Mol Cancer Res 6(5):795-807. doi:10.1158/1541-7786. MCR-07-2097, 6/5/795 [pii]
17. Devillard R, Galvani S, Thiers JC, Guenet JL, Hannun Y, Bielawski J,Negre-Salvayre A, Salvayre R, Auge N (2010) Stress-induced sphingolipid signaling: Role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation. PLoS One 5(3):e9826. doi:10.1371/journal.pone.0009826
18. Filosto S, Fry W, Knowlton AA, Goldkorn T (2010) Neutral sphingomyelinase 2 (nSMase2) is a phosphoprotein regulated by calcineurin (PP2B). J Biol Chem 285(14):10213-10222. doi:10.1074/jbc.M109.069963, M109.069963 [pii]
19. Filosto S, Castillo S, Danielson A, Franzi L, Khan E, Kenyon N, Last J, Pinkerton K, Tuder R, Goldkorn T (2011) Neutral sphingomyelinase 2: A novel target in cigarette smoke-induced apoptosis and lung injury. Am J Respir Cell Mol Biol 44(3):350-360. doi:10.1165/rcmb.2009-0422OC, 2009-0422OC [pii]
20. Filosto S, Ashfaq M, Chung S, Fry W, Goldkorn T (2012) Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines. J Biol Chem 287:514-522. doi:10.1074/jbc.M111.315481, M111.315481 [pii]
21. Gault CR, Obeid LM, Hannun YA (2010) An overview of sphingolipid metabolism: From synthesis to breakdown. Adv Exp Med Biol 688:1-23
22. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect. J Bone Miner Res 17(1):30-38. doi:10.1359/jbmr.2002.17.1. 30
23. Goldkorn T, Filosto S (2010) Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol 43(3):259
24. Grosch S, Schiffmann S, Geisslinger G (2012) Chain length-specific properties of ceramides. Prog Lipid Res 51(1):50-62. doi:10.1016/j.plipres.2011. 11.001, S0163-7827(11)00042-7 [pii]
25. Hama H (2010) Fatty acid 2-hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta 1801(4):405-414
26. Han G, Gupta SD, Gable K, Niranjanakumari S, Moitra P, Eichler F, Brown RH, Harmon JM, Dunn TM (2009) Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl Acad Sci 106(20):8186
27. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 9(2):139-150. doi:10.1038/nrm2329, nrm2329 [pii]
28. Hannun YA, Obeid LM (2011) Many ceramides. J Biol Chem 286(32):27855-27862. doi:10.1074/jbc.R111.254359, R111.254359 [pii]
29. Hayashi Y, Kiyono T, Fujita M, Ishibashi M (1997) cca1 is required for formation of growtharrested confluent monolayer of rat 3Y1 cells. J Biol Chem 272(29):18082-18086
30. Hofmann K, Tomiuk S, Wolff G, StoffelW(2000) Cloning and characterization of the mammalian brain-specific, Mg2 + -dependent neutral sphingomyelinase. Proc Natl Acad Sci U S A 97 (11):5895-5900, 97/11/5895 [pii]
31. Hu W, Xu R, Sun W, Szulc ZM, Bielawski J, Obeid LM, Mao C (2010) Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis. J Biol Chem 285(11):7964-7976. doi:10.1074/jbc. M109.063586, M109.063586 [pii]
32. Ito H, Murakami M, Furuhata A, Gao S, Yoshida K, Sobue S, Hagiwara K, Takagi A, Kojima T, Suzuki M, Banno Y, Tanaka K, Tamiya-Koizumi K, Kyogashima M, Nozawa Y, Murate T (2009) Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin. Biochim Biophys Acta 1789(11-12):681-690. doi:10.1016/j.bbagrm.2009.08.006, S1874-9399(09) 00100-X [pii]
33. Jenkins RW, Canals D, Hannun YA (2009) Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 21(6):836-846
34. Khavandgar Z, Poirier C, Clarke CJ, Li J, Wang N, McKee MD, Hannun YA, Murshed M (2011) A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. J Cell Biol 194(2):277-289. doi:10.1083/jcb.201102051, jcb.201102051 [pii]
35. Kim WJ, Okimoto RA, Purton LE, Goodwin M, Haserlat SM, Dayyani F, Sweetser DA, McClatchey AI, Bernard OA, Look AT, Bell DW, Scadden DT, Haber DA (2008) Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood 111(9):4716-4722. doi:10.1182/blood-2007-10-113068, blood-2007-10-113068 [pii]
36. Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, KronkeM(2006) Novel tumor necrosis factorresponsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein. J Biol Chem 281(19):13784-13793. doi:10.1074/jbc. M511306200, M511306200 [pii]
37. Leventis PA, Grinstein S (2010) The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39:407-427. doi:10.1146/annurev.biophys.093008.131234
38. Levy M, Castillo SS, Goldkorn T (2006) nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. Biochem Biophys Res Commun 344(3):900-905. doi:10.1016/j.bbrc.2006.04.013, S0006-291X(06)00788-1 [pii]
39. Levy M, Khan E, Careaga M, Goldkorn T (2009) Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am J Physiol Lung Cell Mol Physiol 297(1):L125-L133. doi:10.1152/ajplung.00031.2009, 00031.2009 [pii]
40. Long JZ, Cisar JS, Milliken D, Niessen S, Wang C, Trauger SA, Siuzdak G, Cravatt BF (2011) Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids. Nat Chem Biol 7(11):763-765. doi:10.1038/nchembio. 659, nchembio.659 [pii]
41. Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E, Hazen-Martin DJ, Obeid LM, Hannun YA, Smith GK (2002) Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 277(43):41128-41139. doi:10.1074/jbc.M206747200, M206747200 [pii]
42. Mao C, Obeid LM (2008) Ceramidases: Regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta 1781(9):424-434
43. Marchesini N, Osta W, Bielawski J, Luberto C, Obeid LM, Hannun YA (2004) Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells. J Biol Chem 279(24):25101-25111. doi:10.1074/jbc. M313662200, M313662200 [pii]
44. Matmati N, Hannun YA (2008) Thematic review series: Sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases. J Lipid Res 49(5):922-928. doi:10.1194/jlr.R800004-JLR200, R800004-JLR200 [pii]
45. Merrill AH Jr (2011) Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem Rev 111(10):6387
46. Mesicek J, Lee H, Feldman T, Jiang X, SkobelevaA,Berdyshev EV,Haimovitz-FriedmanA, Fuks Z, Kolesnick R (2010) Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal 22(9):1300-1307
47. Milhas D, Clarke CJ, Hannun YA (2010a) Sphingomyelin metabolism at the plasma membrane: Implications for bioactive sphingolipids. FEBS Lett 584(9):1887-1894. doi:10.1016/j.febslet.2009.10.058, S0014-5793(09)00846-1 [pii]
48. Milhas D, Clarke CJ, Idkowiak-Baldys J, Canals D, Hannun YA (2010b) Anterograde and retrograde transport of neutral sphingomyelinase-2 between the Golgi and the plasma membrane. Biochim Biophys Acta 1801(12):1361-1374. doi:10.1016/j.bbalip. 2010.08.001, S1388-1981(10)00179-4 [pii]
49. Mizutani Y, Tamiya-Koizumi K, Nakamura N, Kobayashi M, Hirabayashi Y, Yoshida S (2001) Nuclear localization of neutral sphingomyelinase 1: Biochemical and immunocytochemical analyses. J Cell Sci 114(Pt 20):3727-3736
50. Mullen TD, Obeid LM (2012) Ceramide and apoptosis: Exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med Chem 12:340-363, BSP/ACAMC/E-Pub/00187 [pii]
51. Mullen TD, JenkinsRW, Clarke CJ, Bielawski J,HannunYA, Obeid LM(2011) Ceramide synthasedependent ceramide generation and programmed cell death. J Biol Chem 286(18):15929
52. Mullen TD, Hannun YA, Obeid LM (2012) Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem J 441(3):789-802. doi:10.1042/BJ20111626, BJ20111626 [pii]
53. Nikolova-Karakashian M, Karakashian A, Rutkute K (2008) Role of neutral sphingomyelinases in aging and inflammation. Subcell Biochem 49:469-486. doi:10.1007/978-1-4020-8831-5-18
54. Okamoto Y, Vaena de Avalos S, Hannun YA (2003) Functional analysis of ISC1 by site-directed mutagenesis. Biochemistry 42(25):7855-7862. doi:10.1021/bi0341354
55. Openshaw AE, Race PR, Monzo HJ, Vazquez-Boland JA, Banfield MJ (2005) Crystal structure of SmcL, a bacterial neutral sphingomyelinase C from Listeria. J Biol Chem 280 (41):35011-35017. doi:10.1074/jbc.M506800200, M506800200 [pii]
56. Patti GJ, Yanes O, Shriver LP, Courade JP, Tautenhahn R, Manchester M, Siuzdak G (2012) Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol 8(3):232-234. doi:10.1038/nchembio.767, nchembio.767 [pii]
57. Petcoff DW, Holland WL, Stith BJ (2008) Lipid levels in sperm, eggs, and during fertilization in Xenopus laevis. J Lipid Res 49(11):2365-2378. doi:10.1194/jlr.M800159-JLR200, M800159-JLR200 [pii]
58. Pewzner-Jung Y, Ben-Dor S, Futerman AH (2006) When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J Biol Chem 281(35):25001-25005. doi:10.1074/jbc. R600010200, R600010200 [pii]
59. Philipp S, Puchert M, Adam-Klages S, Tchikov V, Winoto-Morbach S, Mathieu S, Deerberg A, Kolker L, Marchesini N, Kabelitz D, Hannun YA, Schutze S, Adam D (2010) The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase. Proc Natl Acad Sci U S A 107(3):1112-1117. doi:10.1073/pnas.0908486107, 0908486107 [pii]
60. Pitson SM (2011) Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci 36(2):97-107
61. Pruett ST, Bushnev A, Hagedorn K, Adiga M, Haynes CA, Sullards MC, Liotta DC, Merrill AH Jr (2008) Biodiversity of sphingoid bases (" sphingosines") and related amino alcohols. J Lipid Res 49(8):1621-1639. doi:10.1194/jlr.R800012-JLR200, R800012-JLR200 [pii]
62. Qin J, Berdyshev E, Poirier C, Schwartz NB, Dawson G (2012) Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of hyaluronan Synthase 2 through decreased ceramide production and activation of Akt. J Biol Chem 287:13620-13632. doi:10.1074/jbc.M111.304857, M111.304857 [pii]
63. Sawai H, Domae N, Nagan N, Hannun YA (1999) Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J Biol Chem 274 (53):38131-38139
64. Schiffmann S, Ziebell S, Sandner J, Birod K, Deckmann K, Hartmann D, Rode S, Schmidt H, Angioni C, Geisslinger G (2010) Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16: 0-ceramide. Biochem Pharmacol 80(11):1632-1640
65. Schneider PB, Kennedy EP (1967) Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 8(3):202-209
66. Serra M, Saba JD (2010) Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Adv Enzyme Regul 50(1):349
67. Stace CL, Ktistakis NT (2006) Phosphatidic acid- and phosphatidylserine- binding proteins. Biochim Biophys Acta 1761(8):913-926. doi:10.1016/j.bbalip. 2006.03.006, S1388-1981 (06)00067-9 [pii]
68. Stoffel W, Jenke B, Block B, Zumbansen M, Koebke J (2005) Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc Natl Acad Sci U S A 102(12):4554-4559. doi:10.1073/pnas.0406380102, 0406380102 [pii]
69. Stoffel W, Jenke B, Holz B, Binczek E, Gunter RH, Knifka J, Koebke J, Niehoff A (2007) Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression. Am J Pathol 171(1):153-161. doi:10.2353/ajpath.2007. 061285, S0002-9440(10)61951-7 [pii]
70. Sun W, Jin J, Xu R, Hu W, Szulc ZM, Bielawski J, Obeid LM, Mao C (2010) Substrate specificity, membrane topology, and activity regulation of human alkaline ceramidase 2 (ACER2). J Biol Chem 285(12):8995-9007. doi:10.1074/jbc.M109.069203, M109.069203 [pii]
71. Tani M, Hannun YA (2007a) Analysis of membrane topology of neutral sphingomyelinase 2. FEBS Lett 581(7):1323-1328. doi:10.1016/j.febslet.2007.02. 046, S0014-5793(07)00214-1 [pii]
72. Tani M, Hannun YA (2007b) Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization. J Biol Chem 282(13):10047-10056. doi:10.1074/jbc.M611249200, M611249200 [pii]
73. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W (1998) Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling? Proc Natl Acad Sci U S A 95(7):3638-3643
74. Tomiuk S, Zumbansen M, Stoffel W (2000) Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J Biol Chem 275 (8):5710-5717
75. Wu BX, Rajagopalan V, Roddy PL, Clarke CJ, Hannun YA (2010a) Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5. J Biol Chem 285(23):17993-18002. doi:10.1074/jbc.M110.102988, M110.102988 [pii]
76. Wu BX, Clarke CJ, Hannun YA (2010b) Mammalian neutral sphingomyelinases: Regulation and roles in cell signaling responses. Neuromolecular Med 12(4):320-330. doi:10.1007/s12017-010-8120-z
77. Wu BX, Clarke CJ, Matmati N, Montefusco D, Bartke N, Hannun YA (2011) Identification of novel anionic phospholipid binding domains in neutral sphingomyelinase 2 with selective binding preference. J Biol Chem 286(25):22362-22371. doi:10.1074/jbc.M110.156471,M110.156471 [pii]
78. Yabu T, Shimuzu A, Yamashita M (2009) A novel mitochondrial sphingomyelinase in zebrafish cells. J Biol Chem 284(30):20349-20363. doi:10.1074/jbc.M109.004580, M109.004580 [pii]